Tetraploidy: A New Marker for Breast Cancer?

Journal of Carcinogenesis & Mutagenesis
doi 10.4172/2157-2518.1000145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

A New Direction for Breast Cancer Therapy

Science
MultidisciplinaryPhilosophy of ScienceHistory
2016English

Tetraploidy

2020English

In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer

Cancers
Cancer ResearchOncology
2018English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine
Medicine
2017English

New Guidelines for Breast Cancer Screening

Health Affairs
MedicineHealth Policy
2016English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

New Diagnostic Tools for Breast Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2017English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy